Your 100% accurate Kenbe keep your focus on compounding/pimd. Rapimeds may or may not happen and the price from .085 to about .16 in 120 days has NOTHING TO DO WITH RAPIMEDS. THERE IS ZERO EXPECTATION IN RAPIMEDS AND THE HEDGE FUNDS ARE NOT BUYING FOR RAPIMEDS THEY ARE BUYING THE UMDERLYING FUNDAMENTALS OF OUR VERY STRONG COMPOUNDING BUSINESS.
BTW PXYN HAS A GOING CONCERN. SCRC NO LONGER HAS A GOING CONCERN. SCRC HAS 150M O/S. PXYN O/S IS 421M. PRETTY BIG DIFFENCE IN O/S. SCRC HAS A 4M LOC. PXYN HAS NO LOC. SCRC HAS NO MORE CONVERTS. ( OTHER THAN 375K AT .1750 3 FRIENDLY HOLDERS) PXYN HAS NOTES GALORE. I BELIEVE SCRC IS THE BEST PUBLIC COMPANY IN COMPOUNDING IN OUR BB DOMAIN.